Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Aarti Pharmalabs Ltd Financial Statements & Historical Data

Updated NSE: AARTIPHARMBSE: 543748
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 28 September 2026, 9:54 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price914₹ per share
Reported P/E38.5Times
Book value per share234₹ per share
Reported ROCE10.7 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 28 September 2026, 9:54 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap8,293 Cr.
Current Price914
High / Low962/584
Stock P/E38.5
Book Value234
Dividend Yield0.38 %
ROCE10.7 %
ROE8.59 %
Face Value5.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Aarti Pharmalabs Ltd 8,293 Cr. 914 962/58438.5 2340.38 %10.7 %8.59 % 5.00
Sequent Scientific Ltd 8,768 Cr. 201 260/111203 32.20.00 %8.47 %3.21 % 2.00
Bliss GVS Pharma Ltd 7,793 Cr. 738 745/11856.6 1130.20 %16.9 %11.8 % 1.00
Entero Healthcare Solutions Ltd 7,789 Cr. 1,790 1,920/94460.4 3880.00 %10.5 %6.94 % 10.0
Procter & Gamble Health Ltd 8,949 Cr. 5,400 6,975/4,70026.9 3162.87 %83.9 %61.9 % 10.0
Industry Average17,774.69 Cr1,258.9655.96211.600.38%26.16%16.59%6.06

All Competitor Stocks of Aarti Pharmalabs Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 472485458440449506555458538564386418432583536
Expenses 385405373352353388459364409418293344330470400
Operating Profit 868085889611896941291469374102113136
OPM % 18%16%19%20%21%23%17%20%24%26%24%18%24%19%25%
Other Income 010112245-2202148
Interest 56444556107711131713
Depreciation 161617181919202123232325292830
Profit before tax 655964677496747210111565396382101
Tax % 27%27%26%23%29%32%25%24%26%23%24%28%24%25%25%
Net Profit 484347525365555574885028486176
EPS in Rs 5.264.735.205.725.827.206.126.038.169.755.463.085.296.748.40

Last Updated: September 26, 2026, 9:39 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 26, 2026, 9:39 pm

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 01,2001,9451,8532,1151,8191,969
Expenses 09931,6031,4671,6491,4501,543
Operating Profit 0207342386466369426
OPM % 17%18%21%22%20%22%
Other Income 032581523
Interest 0122117274753
Depreciation 042637387104112
Profit before tax 0155261300361233284
Tax % 21%26%28%24%25%
Net Profit 0122193217272175213
EPS in Rs 21.3523.9330.0519.2723.51
Dividend Payout % 0%9%13%17%18%

YoY Net Profit Growth

Year2022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)58.20%12.44%25.35%-35.66%
Change in YoY Net Profit Growth (%)0.00%-45.76%12.91%-61.01%

Aarti Pharmalabs Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2022-2023 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:Not available
5 Years:Not available
3 Years:21%
TTM:0%
Compounded Profit Growth
10 Years:Not available
5 Years:Not available
3 Years:31%
TTM:18%
Stock Price CAGR
10 Years:Not available
5 Years:Not available
3 Years:Not available
1 Year:28%
Return on Equity
10 Years:Not available
5 Years:Not available
3 Years:14%
Last Year:15%

Last Updated: September 5, 2025, 2:01 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 26, 2026, 9:39 pm

MonthMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 0.250.2545454545
Reserves -01,3861,5131,7121,9452,079
Borrowings 0338215285413754
Other Liabilities 0315470540499603
Total Liabilities 02,0402,2442,5822,9023,482
Fixed Assets 07829261,0331,1371,437
CWIP 0187102137374393
Investments 0328710777194
Other Assets 01,0381,1301,3051,3151,457
Total Assets 02,0402,2442,5822,9023,482
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 0-44250216330262
Cash from Investing Activity + 0-139-158-215-412-431
Cash from Financing Activity + 0260-1631065171
Net Cash Flow 078-7112-172
Free Cash Flow 0-18513018-114-186
CFO/OP -11%91%71%85%84%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow0.00-185.00130.0018.00-114.00-186.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 1158410299
Inventory Days 272188230190
Days Payable 12310613590
Cash Conversion Cycle 264166197200
Working Capital Days 11194110105
ROCE %19%16%17%17%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 46.30%46.46%46.46%46.46%46.10%44.65%44.29%43.72%42.88%43.10%43.08%42.86%
FIIs 8.45%8.17%8.33%7.07%7.38%8.64%7.36%7.34%8.02%7.69%8.39%8.17%
DIIs 10.51%9.91%9.97%11.47%11.35%10.36%7.53%7.80%6.95%7.66%7.40%7.22%
Government 0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%
Public 34.73%35.45%35.24%35.00%35.17%36.33%40.81%41.12%42.12%41.54%41.10%41.74%
No. of Shareholders 2,26,2862,15,7962,04,1221,89,0121,85,4361,85,1111,96,3141,87,0391,90,6551,84,4891,79,3731,76,506
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Exports and Services Fund 100,000 0.54 7.4N/AN/AN/A
ICICI Prudential Childrens Fund 88,948 0.47 6.5893,7592026-06-10 04:29:55-5.13%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22
FaceValue 5.005.005.0010.00
Basic EPS (Rs.) 30.0623.9321.3513.49
Diluted EPS (Rs.) 30.0423.9321.3513.49
Cash EPS (Rs.) 39.6432.0128.2536.08
Book Value[Excl.RevalReserv]/Share (Rs.) 219.55193.88171.97304.30
Book Value[Incl.RevalReserv]/Share (Rs.) 219.55193.88171.97304.30
Revenue From Operations / Share (Rs.) 233.36204.42214.64263.36
PBDIT / Share (Rs.) 52.3543.1438.0045.97
PBIT / Share (Rs.) 42.7635.0631.1036.73
PBT / Share (Rs.) 39.8033.1628.7734.10
Net Profit / Share (Rs.) 30.0623.9321.3526.83
NP After MI And SOA / Share (Rs.) 30.0623.9321.3526.83
PBDIT Margin (%) 22.4321.1017.7017.45
PBIT Margin (%) 18.3217.1414.4813.94
PBT Margin (%) 17.0516.2113.4012.94
Net Profit Margin (%) 12.8711.709.9410.18
NP After MI And SOA Margin (%) 12.8711.709.9410.18
Return on Networth / Equity (%) 13.6812.3412.418.81
Return on Capital Employeed (%) 17.2316.8317.1911.46
Return On Assets (%) 9.378.408.675.99
Long Term Debt / Equity (X) 0.050.000.000.00
Total Debt / Equity (X) 0.190.150.130.24
Asset Turnover Ratio (%) 0.770.760.750.00
Current Ratio (X) 2.011.941.951.77
Quick Ratio (X) 1.121.010.930.95
Inventory Turnover Ratio (X) 3.441.381.780.00
Dividend Payout Ratio (NP) (%) 11.648.3510.042.02
Dividend Payout Ratio (CP) (%) 8.826.247.591.50
Earning Retention Ratio (%) 88.3691.6589.9697.98
Cash Earning Retention Ratio (%) 91.1893.7692.4198.50
Interest Coverage Ratio (X) 17.6422.7116.3617.52
Interest Coverage Ratio (Post Tax) (X) 11.1313.6010.1911.22
Enterprise Value (Cr.) 7172.164182.272678.010.00
EV / Net Operating Revenue (X) 3.392.261.380.00
EV / EBITDA (X) 15.1210.707.780.00
MarketCap / Net Operating Revenue (X) 3.212.131.280.00
Retention Ratios (%) 88.3591.6489.9597.97
Price / BV (X) 3.412.241.600.00
Price / Net Operating Revenue (X) 3.212.131.280.00
EarningsYield 0.040.050.070.00
Advertisements
Explore Industry-wise Company financial data